Science Corporation has secured European Union approval for its vision-restoring implant. The device represents a significant milestone in retinal implant technology.
The regulatory approval clears the way for Science Corp to bring its breakthrough device to European patients. The chip is designed to restore functional vision to individuals with certain types of blindness.
CEO Max Hodak emphasized the commercial potential of the sector, stating that sustainable growth requires companies generating substantial annual revenue. "The thing that the space needs is a company making $100 million a year of revenue," Hodak said.
The approval follows years of research and development. Science Corp's technology works by interfacing directly with the visual cortex, bypassing damaged retinas to transmit images to the brain.
The EU authorization positions Science Corp as a key player in the emerging vision-restoration market. Other companies are pursuing similar technologies, but regulatory approval remains a critical hurdle. The device's commercial viability will depend on manufacturing scale, reimbursement decisions by healthcare systems, and continued clinical validation.
Apple is preparing significant updates across its Mac lineup, including the MacBook Neo, iMac, and MacBook Air. The upgrades extend beyond previously reported touchscreen additions.
Samsung has revealed its first smart glasses designs, developed with Google, Gentle Monster, and Warby Parker. The devices will launch this fall with an impressive 9-hour battery life.